Perrigo (PRGO) Shares Outstanding (2012 - 2026)
Perrigo (PRGO) posted quarterly Shares Outstanding (Entity) of $138.1 million for Q1 2026, up 0.66% year-over-year from $137.2 million in Q1 2025, and little changed quarter-over-quarter from $137.6 million in Q4 2025.
Perrigo (PRGO) Shares Outstanding (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Shares Outstanding (Entity) for 15 consecutive years, with $138.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 0.66% year-over-year to $138.1 million; the TTM figure through Mar 2026 stood at $138.1 million (up 0.66% YoY), while the FY2025 annual figure was $137.6 million, up 0.81% from the prior year.
- Shares Outstanding (Entity) held at $138.1 million in Q1 2026 per PRGO's latest filing, from $137.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $138.1 million in Q1 2026 and bottomed at $134.6 million in Q2 2022.
- Historically, Shares Outstanding (Entity) has averaged $136.1 million across 5 years, with a median of $136.3 million in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) gained 0.52% — and 2025, when it advanced 0.88%.
- Perrigo's Shares Outstanding (Entity) stood at $134.7 million in 2022, then grew by 0.59% to $135.5 million in 2023, then climbed by 0.74% to $136.5 million in 2024, then grew by 0.81% to $137.6 million in 2025, then climbed by 0.36% to $138.1 million in 2026.
- Business Quant data shows PRGO's Shares Outstanding (Entity) at $138.1 million in Q1 2026, $137.6 million in Q4 2025, and $137.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Perrigo | 1.89 Bn | 1.49 Bn | 313.90 Mn | 139.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 139.10 Mn |
| Mar 28, 2026 | 138.70 Mn |
| Dec 31, 2025 | 138.50 Mn |
| Sep 27, 2025 | 138.50 Mn |
| Jun 28, 2025 | 138.20 Mn |
| Mar 29, 2025 | 137.70 Mn |
| Dec 31, 2024 | 137.40 Mn |
| Sep 28, 2024 | 137.50 Mn |
| Jun 29, 2024 | 137.10 Mn |
| Mar 30, 2024 | 136.60 Mn |
| Dec 31, 2023 | 135.30 Mn |
| Sep 30, 2023 | 135.50 Mn |
| Jul 1, 2023 | 135.30 Mn |
| Apr 1, 2023 | 134.90 Mn |
| Dec 31, 2022 | 134.50 Mn |
| Oct 1, 2022 | 134.60 Mn |
| Jul 2, 2022 | 134.60 Mn |
| Apr 2, 2022 | 134.00 Mn |
| Dec 31, 2021 | 133.60 Mn |
| Oct 2, 2021 | 133.80 Mn |